Carlsmed, Inc. (CARL) stock
CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30118% above fair value
$17.74+0.39 (+2.25%)
Close on Nov 17, 2026Market cap $484.35MP/E –Yield –
Carlsmed profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Carlsmed's profit margin for the twelve months ending Jun 30, 2026 was -57.4%. For fiscal 2025 it was -58.7%, against -89.3% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -58.7% | +30.6 |
| FY2024 | Dec 31, 2024 | -89.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -55.5% | +0.5 |
| Q1 FY2026 | Mar 31, 2026 | -54.0% | +2.3 |
| Q4 FY2025 | Dec 31, 2025 | -56.8% | −6.6 |
| Q3 FY2025 | Sep 30, 2025 | -65.2% | +53.3 |
| Q2 FY2025 | Jun 30, 2025 | -56.0% | +47.2 |
| Q1 FY2025 | Mar 31, 2025 | -56.2% | – |
| Q4 FY2024 | Dec 31, 2024 | -50.2% | – |
| Q3 FY2024 | Sep 30, 2024 | -118.6% | – |
| Q2 FY2024 | Jun 30, 2024 | -103.2% | – |
See a number that looks wrong?